NFKB1 and neoplasm: Specifically in OS, Felx et al. (48) found that NF-κB pathway activation played a central role in proliferation in the MG-63 human OS cell line, and Zhao et al. (49) reported that the NF-κB pathway was a key regulator of OS tumor growth, metastasis, and resistance to chemotherapeutics.